Skip to main content
Michael Weisman, MD, Rheumatology, Los Angeles, CA

MichaelHWeismanMD

Rheumatology • Los Angeles, CA

Rheumatoid Arthritis & Related, Spondyloarthropathy

Professor, Medicine, UCLA School of Medicine

Join to view full profile

Are you Dr. Weisman?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 88 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    8700 Beverly Blvd.
    Los Angeles, CA 90048
    Phone+1 310-423-2170
    Fax+1 310-423-6898

Summary

  • Dr. Michael Weisman, MD is a rheumatologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is affiliated with Cedars-Sinai Medical Center and Ronald Reagan UCLA Medical Center.

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Internal Medicine, 1969 - 1973
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterInternship, Transitional Year, 1968 - 1969
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1968

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1970 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Device Implants Need Better Labels, Advisers Tell FDA
    Device Implants Need Better Labels, Advisers Tell FDANovember 15th, 2019
  • Modern Medical Terms Are Still Named After Nazi Doctors. Can We Change It?
    Modern Medical Terms Are Still Named After Nazi Doctors. Can We Change It?November 15th, 2012
  • Promising Drug Proves Ineffective as Treatment for Hearing Loss
    Promising Drug Proves Ineffective as Treatment for Hearing LossOctober 8th, 2003
  • Join now to see all

Grant Support

  • Inflammatory Markers In The Stool And Serum Of Patients With Ankylosing SpondyliNational Center For Research Resources2010
  • Project 3: Defining The Spectrum Of Spondyloarthritis In Family MembersNational Center For Research Resources2009–2010
  • Genetic Susceptibility To Lipid-Lowering Drug-Induced MyopathiesNational Center For Research Resources2009–2010
  • A Comprehensive Model Of Severity In Outcomes In Ankylosing SpondylitisNational Center For Research Resources2008–2010
  • Rheumatoid Arthritis Associated Autoimmunity In High Risk PopulationsNational Center For Research Resources2006–2010
  • Clinical Trial: Behavioral Treatments For Rheumatoid ArthritisNational Center For Research Resources2008–2009
  • Genetic Determinants Of Ankylosing Spondylitis Severity: Cross Sectional StudyNational Center For Research Resources2004–2008
  • Behavioral Treatments For Rheumatoid ArthritisNational Center For Research Resources2005–2007
  • Efficacy Of CAM Intervention In Rheumatoid ArthritisNational Center For Research Resources2006
  • Rheumatoid Arthritis Associated Autoimmunity In High Risk Populations:StudNational Center For Research Resources2005
  • Family Studies Of Microsatellite Gene Markers In Patients With AnkylosingNational Center For Research Resources2004–2005
  • Genetic Determinants Of Ankylosing Spondylitis SeverityNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2005
  • Leflunomide VS Placebo For Active Rheumatoid ArthritisNational Center For Research Resources2000–2002
  • Ro32 3555 Trocade In Structural Joint Damage In Rheumatoid ArthritisNational Center For Research Resources1999–2002
  • Hydroxychloroquine Or Acetaminophen In Nodal ArthritisNational Center For Research Resources1999–2002
  • LJP 394 Administered To Patients With Systemic Lupus ErythematosusNational Center For Research Resources1998–2002
  • Anti TNF Chimeric Monoclonal Antibody In Acute Rheumatoid ArthritisNational Center For Research Resources1998–2002
  • Family Studies Of Microsatellite Gene Markers In Ankylosing SpondylitisNational Center For Research Resources2000
  • Recombinant Human Interleukin Eleven In Rheumatoid ArthritisNational Center For Research Resources1999
  • Induction Course &Maintenance Cycle Of Ag4263 In Rheumatoid ArthritisNational Center For Research Resources1999
  • Anti TNF Antibody D2e7 IV Injection In Rheumatoid ArthritisNational Center For Research Resources1999
  • Sc56835 For Treatment Of Osteoarthritis And Rheumatoid ArthritisNational Center For Research Resources1998–1999
  • Oral Colloral In Patients With Rheumatoid ArthritisNational Center For Research Resources1998–1999
  • Long Term Observation Of Patients With Early Rheumatoid ArthritisNational Center For Research Resources1998–1999
  • Stnfr551gg And Methotrexate In Treating Patients With ArthritisNational Center For Research Resources1997–1999
  • Sb210396 In Treatment Of Rheumatoid ArthritisNational Center For Research Resources1996–1999
  • Psychosocial Aspects Of SclerodermaNational Center For Research Resources1996–1999
  • DHEA For Treatment Of Systemic Lupus ErythematosusNational Center For Research Resources1996–1999
  • Study Of Oral Ccii In Treatment Of Active Rheumatoid ArthritisNational Center For Research Resources1995–1999
  • Recombinant Human Interleukin Eleven In Active Rheumatoid ArthritisNational Center For Research Resources1998
  • Osteoarthritis Safety And Pilot Efficacy Study Of L 748,731National Center For Research Resources1996–1997
  • D-Penicillamine In Systemic SclerosisNational Center For Research Resources1995–1997
  • 2cda In The Treatment Of Psoriatic Arthritis And PsoriasisNational Center For Research Resources1995–1997
  • Pharmacodynamic Effective Of Single Dose Of Ljp394 In SLENational Center For Research Resources1996
  • Ljp394 In Patients With Systemic Lupus ErythematosusNational Center For Research Resources1996
  • Three Loading Doses Of Hydroxychloroquine In Rheumatoid ArthritisNational Center For Research Resources1995–1996
  • Three Dosage Regimens Of Stnfr-Igg In Rheumatoid ArthritisNational Center For Research Resources1995–1996
  • Magnesium Repletion &Cyclobenzaprine In Eosinophilia Myalgia SyndromeNational Center For Research Resources1995–1996
  • 2-Chlorodeoxyadenosine Infusion Therapy In Rheumatoid ArthritisNational Center For Research Resources1995–1996
  • Tenidap Sodium And Piroxicam On Biochemical And Tissue Markers In RANational Center For Research Resources1995
  • Safety And Efficacy Of Tolrestat In Limited Joint Mobility In DiabeticsNational Center For Research Resources1995
  • Safety And Efficacy Of Delfazacort In Rheumatoid Arthritis, Pmr, DermatomyositisNational Center For Research Resources1995
  • Phase II Study Of Chimeric Anti-Cd4 And Methotrexate In Rheumatoid ArthritisNational Center For Research Resources1995
  • Rheumatoid Arthritis And Osteoporosis--Piroxicam To Suppress RA DiseaseNational Center For Research Resources1985
  • Relationship Of Breast Augmentatin And Connective Tissue DiseaseNational Center For Research Resources1985
  • Oral Chrysotherapeutic Of Systemic Lupus ErythematosusNational Center For Research Resources1985
  • Efficacy Of Oral GOLD (AURANOFIN) In Treatment Of Rheumatoid ArthritisNational Center For Research Resources1985
  • Double-Blind Comparison Of Injectable Versus Oral GOLDNational Center For Research Resources1985
  • Dietary Management Of Rheumatoid ArthritisNational Center For Research Resources1985
  • Calcium Pyrophosphate Dihydrate Deposition (CPPD) DiseaseNational Center For Research Resources1985

Professional Memberships

Dr. Michael Weisman, Dr. Michael Weisman, MD, Dr. M Weisman, Dr. Michael H Weisman